TCW Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$49M Sell
93,858
-15,093
-14% -$8.27M 0.38% 69
2026
Q2
$57.4M Sell
108,951
-9,800
-8% -$5.5M 0.39% 76
2026
Q1
$66.7M Buy
118,751
+54,007
+83% +$34.6M 0.5% 64
2025
Q4
$43.8M Buy
+64,744
New +$44.1M 0.31% 80
2020
Q1
– Sell
-57,624
Closed -$15M – 316
2019
Q4
$15M Sell
57,624
-11,499
-17% -$3.03M 0.17% 107
2019
Q3
$18.8M Sell
69,123
-6,084
-8% -$1.69M 0.21% 98
2019
Q2
$20.7M Sell
75,207
-19,623
-21% -$4.83M 0.22% 96
2019
Q1
$21.2M Sell
94,830
-8,286
-8% -$1.71M 0.2% 99
2018
Q4
$19.2M Sell
103,116
-9,107
-8% -$1.87M 0.2% 105
2018
Q3
$28M Buy
112,223
+20,986
+23% +$5.09M 0.23% 101
2018
Q2
$19.9M Sell
91,237
-64,140
-41% -$13.2M 0.16% 114
2018
Q1
$29.7M Sell
155,377
-98
-0.1% -$18.1K 0.24% 95
2017
Q4
$24.3M Buy
+155,475
New +$24.5M 0.2% 101

Other funds holding IDXX

TCW Group's IDXX Position: Q3 2026 in Review

TCW Group reduced its Idexx Laboratories (IDXX) stake by 14% in Q3 2026, selling an estimated $8.27M and leaving 93,858 shares worth $49M. The position accounts for 0.38% of the portfolio, ranked #69.

TCW Group first reported a position in IDXX in Q4 2017 and has held it in 13 quarters since. The position peaked at $66.7M in Q1 2026. 1,281 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • TCW Group held 93,858 shares of Idexx Laboratories worth $49M as of Q3 2026.
  • TCW Group sold 15,093 Idexx Laboratories shares in Q3 2026, an estimated $8.27M.
  • Idexx Laboratories made up 0.38% of TCW Group's portfolio in Q3 2026, its #69 holding.
  • TCW Group first reported a position in Idexx Laboratories in Q4 2017 and has held it in 13 quarters since.
  • TCW Group's Idexx Laboratories position peaked at $66.7M in Q1 2026.
  • 1,281 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on TCW Group's 13F filing for Q3 2026, filed 10 Nov 2026.